Total Return chart Lundbeck Nasdaq Copenhagen

Stocks

Real-time Estimate Cboe Europe Other stock markets 10:44:32 2026-08-05 EDT			5-day change	1st Jan Change
35.48 ^DKK	-0.07%		-2.20%	-1.93%

07-23	Lundbeck Receives FDA Fast Track Designation for Lu AH69593, Investigational Orexin 2 Receptor Agonist for Narcolepsy	CI
07-23	Lundbeck Secures US FDA Fast Track Designation for Narcolepsy Drug	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.